Consistently, we observed a significant increase in reactive oxygen species (ROS) (Figure 2c) as well as Δψm depolarization (Figure 2d,e) in B-ALL cells co-treated with Dex and PLC and PKC inhibitors. The gene discussed is PRRT2; the disease is precursor B-cell acute lymphoblastic leukemia.